CIB1 and kidney disorder: Thus, in pursuit of precision medicine and individualized treatment strategies for kidney disorders, KIP will remain an expandable and flexible framework that incorporates additional modalities and welcomes collaborations with colleagues across diverse disciplines, including clinical physicians, pathophysiologists, imaging specialists, omics researchers and artificial intelligence experts, in an effort to accelerate the realization of precision nephrology.